Here are five quick facts about the procedure:
1. Professor Peter Verdonk performed the procedure at AZ Monica Hospital in Belgium.
2. The patient had knee pain, despite previous intervention, and was 47 years old.
3. The surgery took less time than other procedures because of the patient-specific instruments used. Surgeons can customize the surgery to the patient’s anatomy and optimize implant positioning.
4. The Episealer Knee Trochlea achieved a CE-certification in October 2014. The product is offered to selected clinics in Europe via a controlled product launch.
5. The company also has the Episealer Femoral Condyle, which has been on a controlled product launch in the fall of 2013.
More articles on orthopedic devices:
7 key thoughts for choosing new spine technology
Amedica, K2M, VertiFlex & more—13 key notes
8 key thoughts on Stryker’s place in the orthopedic device market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
